Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) EBIT Margin (2016 - 2025)

Historic EBIT Margin for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to 5.71%.

  • cbdMD's EBIT Margin fell 40200.0% to 5.71% in Q4 2025 from the same period last year, while for Dec 2025 it was 12.37%, marking a year-over-year decrease of 4900.0%. This contributed to the annual value of 11.27% for FY2025, which is 53700.0% up from last year.
  • According to the latest figures from Q4 2025, cbdMD's EBIT Margin is 5.71%, which was down 40200.0% from 14.53% recorded in Q3 2025.
  • cbdMD's 5-year EBIT Margin high stood at 1.69% for Q4 2024, and its period low was 373.55% during Q2 2022.
  • For the 5-year period, cbdMD's EBIT Margin averaged around 75.72%, with its median value being 30.21% (2023).
  • In the last 5 years, cbdMD's EBIT Margin tumbled by -3147500bps in 2022 and then skyrocketed by 3453300bps in 2023.
  • Over the past 5 years, cbdMD's EBIT Margin (Quarter) stood at 255.1% in 2021, then soared by 75bps to 64.84% in 2022, then skyrocketed by 69bps to 19.83% in 2023, then surged by 91bps to 1.69% in 2024, then tumbled by -238bps to 5.71% in 2025.
  • Its EBIT Margin was 5.71% in Q4 2025, compared to 14.53% in Q3 2025 and 19.64% in Q2 2025.